Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Brand Name
Metoprolol Succinate
Generic Name
Metoprolol Succinate
Active Ingredient
MetoprololCategory
Thiazide Diuretic [EPC]
Salt Form
Tartrate
Variants
209
References used for this content
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Metoprolol Succinate, you must consult a qualified healthcare professional.
| 100 mg/1 | TABLET, FILM COATED, EXTENDED RELEASE | ORAL | 71205-801 |
| 25 mg/1 | TABLET, EXTENDED RELEASE | ORAL | 71335-0158 |
| 200 mg/1 | TABLET, EXTENDED RELEASE | ORAL | 71335-2334 |
| 25 mg/1 | TABLET, EXTENDED RELEASE | ORAL | 72516-030 |
| 100 mg/1 | TABLET, EXTENDED RELEASE | ORAL | 72516-032 |
| 50 mg/1 | TABLET, EXTENDED RELEASE | ORAL | 72789-010 |
| 25 mg/1 | TABLET, EXTENDED RELEASE | ORAL | 75834-290 |
| 100 mg/1 | TABLET, FILM COATED, EXTENDED RELEASE | ORAL | 75907-345 |
| 100 mg/1 | TABLET, FILM COATED, EXTENDED RELEASE | ORAL | 82868-079 |
+ 38 more variants
Detailed information about Metoprolol Succinate
Metoprolol is a selective beta-1-adrenergic receptor blocker primarily utilized in the management of hypertension, angina pectoris, and the reduction of cardiovascular mortality following myocardial infarction. It belongs to the class of medications known as cardioselective beta-blockers.
Dosage for metoprolol tartrate must be individualized based on the patient's clinical response and tolerance. According to the American College of Cardiology (ACC) guidelines, the following are standard ranges:
The safety and effectiveness of metoprolol tartrate in pediatric patients have not been established by the FDA. While some pediatric cardiologists may use metoprolol off-label for specific conditions like supraventricular tachycardia or hypertension in children, there are no standardized, FDA-approved dosing regimens for patients under 18 years of age. Always consult a pediatric specialist for guidance.
No significant dosage adjustment is typically required for patients with impaired kidney function, as metoprolol is primarily metabolized by the liver. However, monitoring is always recommended in severe cases.
Since metoprolol is extensively metabolized by the liver, patients with significant hepatic impairment (such as cirrhosis) may require lower doses. High plasma levels can occur in these patients, increasing the risk of profound bradycardia (slow heart rate) and hypotension.
In geriatric populations, healthcare providers generally start with the lowest possible dose. Older adults are more susceptible to side effects such as dizziness, falls, and bradycardia. Furthermore, age-related declines in hepatic function may slow the clearance of the drug.
To ensure the best results and minimize side effects, follow these specific instructions:
If you miss a dose of metoprolol, take it as soon as you remember. However, if it is almost time for your next scheduled dose (within 4 hours), skip the missed dose and resume your regular schedule. Never take two doses at once to 'make up' for a missed one, as this can lead to a dangerous drop in heart rate or blood pressure.
An overdose of metoprolol is a medical emergency. Symptoms may include extreme bradycardia (very slow heartbeat), severe hypotension (low blood pressure), heart failure, cardiogenic shock, and bronchospasm (difficulty breathing). In severe cases, it can lead to cardiac arrest. If an overdose is suspected, call 911 or your local emergency services immediately. Emergency treatment often involves the administration of atropine, vasopressors, or glucagon to restore heart function.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop taking metoprolol without medical guidance, as sudden discontinuation can be dangerous.
Metoprolol is generally well-tolerated, but because it slows down certain bodily processes, some side effects are common. According to clinical trial data, the most frequently reported side effects include:
Metoprolol is a potent medication that requires careful monitoring. Patients must be aware that while it protects the heart, it also affects other systems. It is vital to inform your doctor if you have a history of asthma, slow heart rate, or circulation problems before starting this medication.
Abrupt Cessation Risk: The FDA has issued a Black Box Warning for metoprolol. Patients should never stop taking this medication suddenly. Abruptly ending beta-blocker therapy can cause 'rebound' symptoms, including severe chest pain, dangerously high blood pressure, and even heart attacks. If you need to stop metoprolol, your doctor will provide a tapering schedule to slowly lower your dose over 7 to 14 days.
There are certain medications that should never be used alongside metoprolol due to the risk of life-threatening complications:
Metoprolol must NEVER be used in patients with the following conditions:
Metoprolol is classified as FDA Pregnancy Category C. This means that animal studies have shown adverse effects on the fetus, but there are no adequate, well-controlled studies in humans. According to data from the American College of Obstetricians and Gynecologists (ACOG), metoprolol crosses the placenta. Use during pregnancy may lead to fetal bradycardia (slow heart rate), hypoglycemia, and low birth weight. It should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus. If you are pregnant or planning to become pregnant, discuss alternative treatments for hypertension with your doctor.
Metoprolol is excreted into breast milk in small amounts. While the amount a nursing infant receives is generally considered low, there have been reports of beta-blockade effects in infants, such as a slow heart rate. The American Academy of Pediatrics suggests that metoprolol is generally compatible with breastfeeding, but infants should be monitored for signs of bradycardia or respiratory distress. Consult your pediatrician before breastfeeding while taking this medication.
Metoprolol is a cardioselective competitive antagonist at the beta-1-adrenergic receptors. It has little to no intrinsic sympathomimetic activity (ISA) and little membrane-stabilizing activity (MSA) at therapeutic doses. By binding to beta-1 receptors in cardiac tissue, it inhibits the stimulation of adenylate cyclase by catecholamines. This leads to a decrease in intracellular cyclic AMP (cAMP), which in turn reduces the calcium influx into cardiac cells. The end result is a decrease in heart rate, a decrease in myocardial contractility, and a slowing of conduction through the atrioventricular (AV) node.
The onset of action for oral metoprolol tartrate is typically within 1 hour, with peak effects occurring between 1 and 2 hours. The duration of the antihypertensive effect is dose-related but generally lasts for about 12 hours with the tartrate form. Metoprolol does not usually cause postural hypotension in normal subjects. It reduces the heart rate and cardiac output both at rest and during exercise, and it reduces the surge in blood pressure that occurs with physical or emotional stress.
| Parameter | Value |
Common questions about Metoprolol Succinate
Metoprolol is primarily used to treat high blood pressure (hypertension), which helps prevent strokes, heart attacks, and kidney problems. It is also frequently prescribed to treat chest pain (angina) by improving blood flow and reducing the heart's workload. Additionally, it is a vital medication used after a heart attack to improve survival rates and prevent future cardiac events. Some doctors may also use it off-label for conditions like migraines or irregular heartbeats. Always take it exactly as your healthcare provider directs for your specific condition.
The most common side effects of metoprolol include fatigue, dizziness, and a slower-than-normal heart rate. Many patients also report feeling lightheaded when they stand up quickly or noticing that their hands and feet feel colder than usual. Gastrointestinal issues like mild nausea or diarrhea can also occur in some people. Most of these side effects are mild and often improve as your body gets used to the medication. However, if they persist or become bothersome, you should consult your doctor to discuss a possible dose adjustment.
It is generally recommended to avoid or strictly limit alcohol while taking metoprolol. Alcohol can increase the blood-pressure-lowering effects of the drug, which may lead to extreme dizziness, lightheadedness, or even fainting. In some cases, alcohol can also interfere with how the medication is processed by your liver. If you do choose to drink, do so in moderation and only after you know how metoprolol affects you. Always discuss your alcohol consumption habits with your healthcare provider before starting a new heart medication.
Metoprolol is considered a Pregnancy Category C medication, meaning its safety is not fully established in humans. It can cross the placenta and may cause side effects in the developing fetus, such as a slow heart rate or low birth weight. Doctors usually only prescribe it during pregnancy if the benefits to the mother's heart health clearly outweigh the potential risks to the baby. If you are pregnant or planning to conceive, it is crucial to have a detailed discussion with your obstetrician and cardiologist. They may suggest alternative medications that have a more established safety profile during pregnancy.
For conditions like high blood pressure, you may start to see a reduction in your readings within a few days, but the full effect often takes one to two weeks of consistent use. If you are taking it for angina, you may notice a decrease in the frequency of chest pain shortly after starting therapy. For those taking it after a heart attack, the protective benefits begin almost immediately after the first dose. It is important to keep taking the medication even if you feel well, as hypertension often has no symptoms. Do not stop the drug if you don't see immediate results without talking to your doctor.
No, you should never stop taking metoprolol suddenly, as it carries a serious FDA Black Box Warning regarding abrupt discontinuation. Stopping the drug all at once can cause a 'rebound' effect, leading to a rapid heart rate, severe chest pain, and a significant spike in blood pressure. In some cases, this has even triggered heart attacks in patients with underlying heart disease. If you need to stop the medication, your doctor will provide a tapering schedule to slowly reduce your dose over one to two weeks. Always ensure you have enough refills so you do not accidentally run out.
If you miss a dose of metoprolol, take it as soon as you remember. However, if your next scheduled dose is less than 4 hours away, you should skip the missed dose and simply take your next one at the regular time. Never take two doses at once to make up for the one you missed, as this could cause your heart rate or blood pressure to drop to dangerous levels. If you find yourself frequently forgetting doses, consider using a pill organizer or setting a daily alarm on your phone. Consistency is vital for managing heart conditions effectively.
Weight gain is not a common side effect of metoprolol, but it can occur in some patients. This is often due to the fatigue the medication causes, which might lead to decreased physical activity. In some cases, beta-blockers can slightly slow down your metabolism. However, if you notice sudden or rapid weight gain accompanied by swelling in your ankles or shortness of breath, this could be a sign of worsening heart failure rather than simple weight gain. You should report any significant changes in weight to your healthcare provider immediately for a full evaluation.
Metoprolol can interact with many other drugs, including some over-the-counter medications and herbal supplements. It is particularly important to tell your doctor if you take other blood pressure medicines, certain antidepressants like Prozac or Paxil, or heart rhythm medications like digoxin. Even common NSAIDs like ibuprofen can reduce the effectiveness of metoprolol. Because of these potential interactions, you should provide your doctor and pharmacist with a complete list of everything you take. They can then monitor you for side effects or adjust your dosages as necessary to ensure your treatment is safe.
Yes, metoprolol is widely available as a generic medication in both its tartrate and succinate forms. Generic versions are required by the FDA to have the same active ingredient, strength, and effectiveness as the brand-name versions like Lopressor or Toprol-XL. Choosing the generic version can significantly lower your out-of-pocket costs at the pharmacy. Most insurance plans prefer the generic form. If you have any concerns about switching from a brand-name to a generic, or between different generic manufacturers, discuss them with your pharmacist to ensure you receive a consistent supply.
Other drugs with the same active ingredient (Metoprolol)
> Warning: Stop taking Metoprolol and call your doctor immediately if you experience any of these serious symptoms:
With prolonged use, some patients may develop a tolerance to the side effects, while others may notice persistent issues. Long-term use of beta-blockers has been studied for its effects on glucose metabolism; metoprolol may slightly increase the risk of developing Type 2 diabetes in predisposed individuals or mask the symptoms of low blood sugar (hypoglycemia). Additionally, some patients may experience 'beta-blocker withdrawal' if the drug is stopped suddenly after years of use, characterized by a rapid heart rate and a spike in blood pressure.
Metoprolol carries a critical FDA Black Box Warning regarding the risks of abrupt discontinuation.
Summary of Warning: In patients with coronary artery disease, suddenly stopping metoprolol can lead to an exacerbation of angina, heart attack (myocardial infarction), or ventricular arrhythmias. When discontinuing therapy, the dosage should be gradually reduced over a period of 1 to 2 weeks under the close supervision of a healthcare provider. If angina worsens during the tapering process, the medication should be temporarily reinstated.
Report any unusual symptoms to your healthcare provider promptly to ensure your treatment plan remains safe and effective.
Your healthcare provider will likely require regular follow-up appointments to monitor your progress:
Metoprolol can cause dizziness, fatigue, and blurred vision, especially when you first start taking it or when your dose is increased. Do not drive or operate heavy machinery until you know how the medication affects you. If you feel lightheaded, sit or lie down immediately.
Alcohol can enhance the blood-pressure-lowering effects of metoprolol, leading to increased dizziness and the risk of fainting. It is generally advised to limit or avoid alcohol consumption while taking this medication. Furthermore, alcohol can increase the rate at which extended-release versions of metoprolol are released into the system, though this is less of a concern with the tartrate form.
As noted in the Black Box Warning, discontinuation must be gradual. If you miss multiple doses or run out of your prescription, contact your doctor immediately. Do not wait until you feel symptoms of withdrawal to seek help.
> Important: Discuss all your medical conditions, including any history of depression or respiratory issues, with your healthcare provider before starting Metoprolol.
Metoprolol may interfere with certain medical tests:
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter pain relievers.
In these cases, the healthcare provider must carefully weigh the benefits against the risks:
Patients who have had an allergic reaction to other beta-blockers (such as atenolol, propranolol, or carvedilol) are at a higher risk of being allergic to metoprolol. Always inform your doctor of any past drug allergies.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Metoprolol to ensure none of these conditions are present.
Clinical studies indicate that elderly patients may be more sensitive to the effects of metoprolol. There is an increased risk of:
Healthcare providers typically 'start low and go slow' with dosing in this population.
For patients with kidney disease, metoprolol is generally considered safe because it is primarily cleared by the liver. No specific dose adjustments are mandated for renal failure or for patients on hemodialysis, as metoprolol is not significantly removed by dialysis. However, general monitoring of blood pressure is always necessary.
Metoprolol is extensively metabolized by the liver. In patients with significant hepatic impairment, such as cirrhosis or hepatitis, the 'first-pass' metabolism is reduced, and the half-life of the drug is prolonged. This can lead to much higher concentrations of the drug in the blood. Patients with liver disease require careful dose titration and frequent monitoring for side effects like extreme fatigue and slow heart rate.
> Important: Special populations require individualized medical assessment and frequent follow-up to ensure safety.
| Bioavailability | ~40% to 50% (increases with food) |
| Protein Binding | ~12% (primarily to albumin) |
| Half-life | 3 to 7 hours |
| Tmax | 1.5 to 2 hours |
| Metabolism | Hepatic (primarily CYP2D6) |
| Excretion | Renal (95% as metabolites, <5% unchanged) |
Metoprolol belongs to the therapeutic class of Beta-Adrenergic Blocking Agents and the sub-class of Selective Beta-1 Blockers. Other medications in this class include atenolol, bisoprolol, and nebivolol. Unlike non-selective blockers like propranolol, metoprolol has a higher affinity for the receptors in the heart than those in the lungs, making it a preferred choice for many cardiovascular patients.